The 6 references without contexts in paper O. Kit I., E. Frantsiyants M., E. Rostorguev E., I. Balyazin-Parfenov V., N. Cheryarina D., L. Kozlova S., Yu. Pogorelova A., О. Кит И., Е. Франциянц М., Э. Росторгуев Е., И. Балязин-Парфенов В., Н. Черярина Д., Л. Козлова С., Ю. Погорелова А. (2016) “Некоторые факторы роста в тканях новообразований головного мозга различной гистологической структуры // Some growth factors in neoplastic tissues of brain tumors of different histological structure” / spz:neicon:ogsh:y:2016:i:3:p:27-33

19
Almeida L.O., Custódio A.C., Santos M.J. et al. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival. Cancer Genet Cytogenet 2010;198(1):15–21.
(check this in PDF content)
20
Bhuiyan M.I., Kim J.C., Hwang S.N. et al. Ischemic tolerance associated with VEGF-C and VEGFR-3 signaling in the hippocampus of mice. Neuroscience 2015;290:90–102.
(check this in PDF content)
21
Shin Y.J., Riew T.R., Park J.H., Lee M.Y. Expression of Vascular Endothelial Growth Factor-C (VEGF-C) and its receptor (VEGFR-3) in glial reaction caused by human mesenchymal stem cell engraftment in normal rat brain. J Histochem Cytochem 015;63(3):170–80.
(check this in PDF content)
22
Xu Y., Zhong Y.J, Zhang W.Q, Song, J.H. Cooverexpression of matrix metalloproteinases-1 and vascular endothelial growth factor-C predicts poor prognosis in patients with glioma. Epidemiol 2013;37(5):697–702.
(check this in PDF content)
23
Grau S., Thorsteinsdottir J., von Baumgarten L. et al. Bevatsizumab May cause reactivity to VEGF-C and -D in the human brain and tumor derived endothelial cells. J Neurooncol 2011;104(1): 103–12.
(check this in PDF content)
24
Shin Y.J., Choi J.S., Lee J.Y. et al. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 2008;116(5):517–27.
(check this in PDF content)